Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden.
- 1 June 1990
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 87 (12) , 4421-4425
- https://doi.org/10.1073/pnas.87.12.4421
Abstract
Hemophilia B Leyden is characterized by unusual developmental regulation of factor IX synthesis in affected individuals. One family affected with the hemophilia B Leyden phenotype was found to have a specific single-base mutation (G .fwdarw. A) at nucleotide -6 of the factor IX gene. The mutation site was found in a small region of the 5''-untranslated sequence designated the Leyden-specific region (LS region). This region, .apprxeq. 40 base pairs in length, contains the unique mutation sites of all the known factor IX Leyden genes (five families) analyzed to date. This fact strongly suggests that the LS region is directly or indirectly involved in the developmental regulation of factor IX biosynthesis. Base changes at nucleotide -20 as well as at nucleotide -6 and deletions of the 3'' half of the LS region reduced expression activity of the factor IX gene to .apprxeq. 15-31% that of the normal control, as assessed in a cultured cell (HepG2) expression system. The LS region binds at least two proteins. Androgen significantly increased the transcriptional activities of both mutant and normal factor IX genes in a concentration-dependent manner.This publication has 26 references indexed in Scilit:
- Tat trans-activates the human immunodeficiency virus through a nascent RNA targetCell, 1989
- HIV-1 Tat protein increases transcriptional initiation and stabilizes elongationCell, 1989
- EUKARYOTIC TRANSCRIPTIONAL REGULATORY PROTEINSAnnual Review of Biochemistry, 1989
- Binding of a Cytosolic Protein to the Iron-Responsive Element of Human Ferritin Messenger RNAScience, 1988
- Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen ReceptorsScience, 1988
- The Prophylactic Treatment of Hemophilia B Leyden with Anabolic SteroidsAnnals of Internal Medicine, 1985
- Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)Biochemistry, 1985
- ‘Normal’ haemostasis parameters: a study in a well-defined inborn population of preterm infantsEarly Human Development, 1984
- Danazol Increases Factor VIII and Factor IX in Classic Hemophilia and Christmas DiseaseNew England Journal of Medicine, 1983
- Hemophilia B LeydenNew England Journal of Medicine, 1982